Christian, Husband, Father, Son... Sr. Mechanical Design Engineer (30 yrs) Hobbies- Hunting, fishing, spending time outdoors, tinkering and fixer of many things
$NWBO 🚨 The situation surrounding $NWBO is becoming incredibly compelling.
Dr. Mehmet Oz, the head of CMS (Centers for Medicare & Medicaid Services), has publicly discussed the extraordinary case of an 18-year-old patient with Stage IV glioblastoma—who reportedly achieved NED (No Evidence of Disease) status after treatment with DCVax-L—and stated his intention to investigate the case.
This is not just another post from an investor. A high-ranking U.S. health official revealed that news of this case came to him directly from the President.
If medical records confirm the details, the potential impact would be massive: national media attention, independent medical review, and a significant boost in DCVax-L's profile.
We know this is by no means an isolated case. Dr. Oz will discover this, potentially triggering a much broader investigation.
The spotlight is intensifying.
🔦 $NWBO $DCVAX
Diamond Hands 💎 🙌
HODL
MOASS100
@MrWhiplash_ I want to hear what said. Did she insult one tbe counselmen, did use profanity? Either way its freedom of speech but these tyrants will not allow it.
If you truly to stop them you will be arrested too.
What's the ticket on that? Do we need a really need another carved up stone to look at? Seriously, think abt it. How abt taking that money and pay off the pharmaceutical companies. Then
brain tumor cancer patients would have the "Right to Try" NK cell, DCVax, Anktiva and others.
30 years of "Standard care " with minimal increase of survival rates is pathetic!
This administration is totally out of touch with the people.
@Av8rLady@nicksortor I know. I saw that too, but there is no telling how many cancer there are at The Ingram Center. I always liked Dolly. She had a good heart.
@SenKatieBritt 80% of the American ppl want secure elections. Why didn't you say that. Stand up for the American people, thats your job! If the SAA, doesnt pass, I dont care what Republican is running against you but the have my vote!
$NWBO
Amanda Hollensbe is fighting to save her daughter Braelyn’s life.
She wrote this letter to the UK Prime Minister and the Chief Executive of the MHRA
Braelyn spent much of the summer in London so she could get her first three doses of DCVax - a non-toxic glioblastoma vaccine made by an American company.
A promising treatment U.S. regulators still won’t approve.
The data is there.
10-and 20-year + glioblastoma survivors exist.
The UK gave her a chance.
Regulators everywhere are still moving like they have all the time in the world.
Glioblastoma patients don’t.
Video #11 (other videos are in this thread. Please repost)
@HollensbeAmanda@gr197667@andrewcaravello@MHRAgovuk@RobertKennedyJr
🔥���HEY NOW DR. LIAU🔥🔥
$NWBO's brain cancer expert just landed a major award for the exact science she built around DCVax.
Dr. Linda Liau took home the 2026 UCLA Younes Nazarian Medical Humanitarian Prize.
Decades of brain cancer research and treatment recognized.
The award hits clinical care, research, and real innovation.
She pioneered functional imaging for awake brain surgery.
And developed the first personalized brain cancer vaccine.
That vaccine? DCVax-L.
In 1999 her UCLA team ran the first human test of a dendritic cell-based brain cancer vaccine.
Her work led straight to DCVax-L.
Northwest Biotherapeutics partnered with Liau on two Phase I/II DCVax-L trials at UCLA.
She served as Principal Investigator on the Phase 3 glioblastoma trial.
Results dropped in JAMA Oncology.
September 2023: Liau joins NWBO’s Scientific Advisory Board.
They cited her neuro-oncology leadership, decades in immunotherapy, and deep DCVax-L experience.
Most of her recognized brain cancer immunotherapy work sits right on the dendritic cell vaccine platform that became DCVax-L.
This award locks in the scientific foundation.
Recognition at this level for her immunotherapy and vaccine work delivers a BULLISH signal for the credibility of the DCVax approach she helped pioneer and study.
Congrats Dr. Liau 🔥🔥